Revenue segments as reported by the company.

Pharmacy revenues

Premiums

Fees and other revenues

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Pharmacy and other service costs

Medical costs and other benefit expenses

Selling, general and administrative expenses

Amortization of acquired intangible assets

Special items

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cigna

Express Scripts is a company that provides integrated pharmacy benefit management services including network-pharmacy claims processing; home delivery pharmacy services; specialty pharmacy benefit management, through its subsidiary Accredo; benefit-design consultation; drug-utilization review; formulary management; and medical and drug data analysis services to manage drug plans for health plans, self-insured employers and government agencies (both as administrator of employee benefits and public assistance programs). Express Scripts also offers pharmacy benefit management services for workers' compensation insurance programs. The program is accredited by URAC, the nation's largest accrediting body for pharmacy benefit management companies. The company processes pharmaceutical claims for members through a network of retail pharmacies. Its own automated pharmacies dispense long-term, chronic medications-like those for diabetes or heart disease-directly to members by home delivery.

Express Scripts

The Cigna Group is a global health company, which engages in the provision of global health services. It operates through the following segments: Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate. The Evernorth Health Services segment partners with health plans, employers, governmental organizations, and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. The Cigna Healthcare segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. The Other Operations segment consists of the remainder of business operations, which includes certain ongoing businesses and exited businesses. The Corporate segment refers to net interest expense, certain litigation matters, expense associated with frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs, and eliminations for products and services sold between segments. The company was founded in 1792 and is headquartered in Bloomfield, CT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cigna posts strong Q4 earnings, eyes growth in specialized services

Cigna delivered strong financial results in Q4 2022, with robust revenue growth and operational performance across key business segments.
While facing challenges such as margin pressures and potential disenrollment, Cigna is well-positioned to capitalize on growth opportunities in 2023.
Strategic partnerships, customer-focused strategies, and financial discipline underscore Cigna's commitment to sustainable growth and shareholder value creation.
Investments in innovation, care coordination, and market expansion signal a proactive approach to navigating industry dynamics and driving future success.

Cigna reports robust Q1 earnings, eyes growth amid challenges

Cigna's Q1 2023 showcased strong financials, growth in key segments, and increased outlook.
Challenges include economic softening impact and margin expectations for the year.
Opportunities lie in customer relationships, innovation, and market-specific strategies.
Overall, Cigna remains confident in delivering on its financial and growth targets.

Cigna reports robust Q2 results, eyes growth through innovation

Cigna's Q2 2023 performance was strong, with revenue growth, customer expansion, and technological advancements driving positive outcomes.
While facing challenges like disenrollment and risk adjustment payables, Cigna is leveraging strengths in technology and cross-selling for growth.
Opportunities lie in partnerships like VillageMD, continued innovation, and strategic bidding strategies for future growth.
Overall, Cigna remains confident in delivering on adjusted EPS outlook for 2023 and 2024, with a focus on innovation and growth.

Cigna surpasses Q3 expectations, eyes $28 EPS in 2024

Cigna's Q3 performance exceeded expectations, driven by strong revenue and EPS growth across key business segments.
Strategic focus on innovation, affordability, and client partnerships positions Cigna well for future growth and value creation.
Challenges in margin expectations and enrollment declines require proactive management and strategic decision-making.
Opportunities lie in continued growth projections, strategic investments, and enhancing healthcare affordability and accessibility.

Cigna reports robust Q4 performance, eyes growth amid strategic changes

Cigna Group's Q4 2023 Earnings Call highlighted strong financial performance, leadership changes, and strategic decisions. Analyst inquiries focused on growth drivers, market outlook, and internal healthcare spend management. The outlook for 2024 includes expectations of solid adjusted EPS, revenue growth, and operating cash flow.

Cigna surpasses Q1 expectations, eyes growth through AI and biosimilars

Cigna's Q1 performance exceeded expectations, driven by strong revenue and EPS figures.
Despite challenges like noncash losses and disruptions, Cigna's strategic strengths in AI, biosimilars, and value-based care position it well for growth.
Opportunities in AI-driven healthcare solutions, biosimilar expansions, and strategic M&A offer avenues for future growth.
Cigna's focus on precision care solutions and client outcomes showcases its commitment to innovation and efficiency.

Cigna (CI) posts robust Q2 results, eyes biosimilar growth

Cigna (CI) reports strong Q2 financial results driven by Evernorth Health Services and Express Scripts' innovative programs.
Focus on affordability, access, and behavioral health services propels growth in U.S. employer business.
Challenges include navigating healthcare cost pressures and ensuring fair pricing negotiations.
Opportunities lie in biosimilar growth, sustainable revenue outlook, and strategic Medicare Advantage business sale.

Cigna reports robust Q3 earnings, eyes growth opportunities in 2025

Cigna's Q3 earnings call highlighted strong financial performance, strategic focus on shareholder value, and challenges in specialty drugs and cost trends. The company is optimistic about opportunities in 2025 and remains committed to delivering shareholder value through strategic initiatives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Bank of America

Domino's Pizza

Elevance Health Inc

Global Payments

Mastercard

Microchip Technology

Monolithic Power Systems

MSCI

NIKE

Old Dominion Freight Line

Rollins

Sirius XM Holdings Inc

UnitedHealth Group

Zoetis

The SPDR S&P 500 ETF Trust had a 5.22% return in February, outperforming Vanguard's Dividend Appreciation Index Fund ETF Shares.

My Top 15 High Growth Dividend Stocks For March 2024

Ameriprise Financial

Amazon

Apollo Global Management

American States Water

Booking Hlds

Caterpillar

Salesforce

Coterra Energy

EOG Resources

Humana

Lear

Lowe's

Magna International

National Fuel Gas

Novartis

PNC Financial Services

PayPal

Shell PLC

Last week saw a rally in Nvidia stock, causing nervousness among value and income investors. There were opportunities to buy quality companies at good or even great valuations even during the tech bubble. Growth at a reasonable price (GARP) is one potential time-tested way to beat the market long term. Super GARP investing, combining GARP with quality screens, could be better.

20 GARP Blue-Chip Bargains To Buy Now

Cigna (CI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Cigna Group (CI) Hits Fresh High: Is There Still Room to Run?

BLOOMFIELD, Conn. , Feb. 27, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that Brian Evanko, executive vice president and chief financial officer, will present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024, in Miami, FL.

The Cigna Group Announces Appearance at Barclays 26th Annual Global Healthcare Conference

NEW YORK--(BUSINESS WIRE)--Cigna Healthcare has selected Baron Capital as a recipient of their 2023 Gold level Healthy Workforce Designation for demonstrating a strong commitment to improving the health and vitality of its employees through a workplace well-being program. “At Baron Capital, our Health and Wellness Program is designed to empower our team members to take charge of their health by providing them with the necessary knowledge and resources,” said Emmanuelle St. Louis, Baron Capital.

Baron Capital Recognized with 2023 Cigna Healthy Workforce Designation ™

Cigna has a strong track record of revenue growth and is a giant in the healthcare industry.

Cigna: Big Buybacks And Total Return Potential

CHICAGO--(BUSINESS WIRE)--Tempus, a leader in artificial intelligence and precision medicine, today announced that the company has signed an agreement for in-network provider status with Cigna Healthcare. The collaboration signifies an important stride in enhancing accessibility to Tempus' array of molecular profiling tests for Cigna's extensive network, which comprises approximately 16 million members. At the core of Tempus' offerings is a comprehensive molecular profiling portfolio that equip.

Tempus Expanding Access to its Next-Generation Sequencing Tests as an In-Network Provider for Cigna

BLOOMFIELD, Conn. , Feb. 20, 2024 /PRNewswire/ -- The Cigna Group (NYSE: CI) announced today the pricing terms of its previously announced offers to purchase for cash (1) any and all of The Cigna Group's (the " Company ") 3.50% Senior Notes due 2024 and Evernorth Health, Inc.'s (" Evernorth ") 3.50% Senior Notes due 2024 (collectively, the " Any and All Notes ," and such tender offer, the " Any and All Tender Offer ") and (2) up to $1,550,000,000 aggregate principal amount (the " Maximum Tender Offer Amount ") of the Company's 4.125% Senior Notes due 2025, the Company's 4.500% Senior Notes due 2026, Evernorth's 4.500% Senior Notes due 2026, the Company's 1.250% Senior Notes due 2026, the Company's 3.050% Senior Notes due 2027, Cigna Holding Company's 3.050% Senior Notes due 2027 and the Company's 2.400% Senior Notes due 2030 (collectively, the " Maximum Tender Offer Notes ," and such tender offer, the " Maximum Tender Offer "), in each case, validly tendered and accepted by the Company, upon the terms and subject to the conditions set forth in the Offer to Purchase dated February 5, 2024 and as amended by the press release dated the date hereof announcing the early results of the Tender Offers (as defined below) and the upsize of the Maximum Tender Offer (the " Offer to Purchase ").

The Cigna Group Announces Pricing Terms of Tender Offers

Cigna (CI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Cigna (CI) Upgraded to Buy: What Does It Mean for the Stock?

BLOOMFIELD, Conn. , Feb. 20, 2024 /PRNewswire/ -- The Cigna Group (NYSE: CI) announced today the results as of 5:00 p.m.

The Cigna Group Announces Early Results of Tender Offers and Upsize of Maximum Tender Offer

Assurant

Ares Management

Broadcom

Costco

Carlisle Companies

Dick's Sporting Goods

Comfort Systems USA

Intuit

Microsoft

Owens Corning

PACCAR

Parker-Hannifin

PulteGroup

Wingstop

This article focuses on selecting high-growth dividend stocks that have rapidly grown their dividends in the recent past rather than simply sport a high current yield. We use our proprietary models to rate quantitatively and qualitatively and select the top ten names from an initial list of nearly 400 dividend stocks. The article provides criteria for selecting high-growth dividend stocks. It offers a step-by-step guide on structuring a portfolio based on this strategy.

Our Top 10 Dividend Growth Stocks - February 2024

Ford Motor Company

Uber

Positive guidance is one of the most bullish announcements shareholders can hear, injecting confidence in the future picture. And that's precisely what these three companies have announced.

These 3 Companies Recently Provided Rosy Guidance

BLOOMFIELD, Conn. , Feb. 15, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) will repurchase $3.2 billion of common stock through accelerated stock repurchase agreements (the "ASR Agreements") with Deutsche Bank AG and Bank of America, N.A.

The Cigna Group Announces $3.2 Billion Accelerated Stock Repurchase

HelloFresh's meal-kit options are now available to Cigna Healthcare clients at exclusive discounted rates Collaboration will also focus on combatting food insecurity by providing free meal kits to communities in need BLOOMFIELD, Conn. and NEW YORK , Feb. 13, 2024 /PRNewswire/ -- Cigna Healthcare, the health benefits division of The Cigna Group (NYSE: CI), and HelloFresh*, the world's leading meal kit company, announce an exclusive collaboration to offer discounted access to HelloFresh's wholesome, affordable meals to as many as 12 million Cigna Healthcare customers through their employers.

Cigna Healthcare and HelloFresh Team Up To Expand Access to Affordable, Healthy Meal Choices

Centene

Molina Healthcare

Growing customer base and M&A strategies are likely to aid the Medical-HMO industry. However, escalating expenses and a dearth in the availability of medical personnel are concerning.

3 HMO Stocks in Focus Despite High Tech Costs & Nursing Shortage

The Cigna Group's NYSE: CI 35% rally that started last summer just hit a new high gear. While investors would have been spooked by the 20% slide from November into December, all that damage has since been undone, and then some.

Why Cigna stock will be at fresh highs by March

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned Long-Term Issue Credit Ratings (Long-Term IRs) of “bbb+” (Good) to The Cigna Group's (Cigna) (headquartered in Bloomfield, CT) [NYSE:CI] recently issued $1 billion 5% senior unsecured notes, due 2029, $750 million 5.125% senior unsecured notes, due 2031, $1.25 billion 5.25% senior unsecured notes, due 2034 and the $1.5 billion 5.6% senior unsecured notes, due 2054. The outlook assigned to these Credit Ratings (ratings) is stable. Cigna's Long.

AM Best Assigns Issue Credit Ratings to The Cigna Group's New Senior Unsecured Notes

Church & Dwight

Imperial Oil

Ramaco Resources

PACCAR Inc (PCAR), Church & Dwight Co., Inc. (CHD), Imperial Oil Limited (IMO), Ramaco Resources, Inc. (METC) and The Cigna Group (CI) recently hiked their dividends.

5 Stocks to Watch That Recently Announced Dividend Hikes

Lead Sponsor Cigna Healthcare Provided Free Biometric Health and Skin Cancer Screenings  to Faculty, Parents, and Community Members and Free Eye Exams and Glasses to PreK-5 Students  Zebra Technologies Sponsored Leave-Behind Mural Designed by Courtney "Yard$" Haywood  Joining the Team This Year are CBS Sports and Nickelodeon LAS VEGAS , Feb. 6, 2024 /PRNewswire/ -- Today, NFL legend and executive Troy Vincent, Sr. and his wife, Tommi A. Vincent, a renowned chef, podcast host, and philanthropist, hosted their seventh annual "Vincent Country Safe Zone Activity Day," a Love Thy Neighbor Community Development and Opportunity Corporation, at Matt Kelly Elementary School in Las Vegas, NV during Super Bowl LVIII Week.

SEVENTH ANNUAL "VINCENT COUNTRY SAFE ZONE ACTIVITY DAY" THEMED DREAM BIGGER, ACHIEVE GREATER HELD AT MATT KELLY ELEMENTARY DURING SUPER BOWL LVIII WEEK IN LAS VEGAS, NV

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Cigna (CI) is a Top-Ranked Value Stock: Should You Buy?

News for Cigna Stock (CI)